What does CUSIP 09061G101 represent in this 13F holders report?

CUSIP 09061G101 is the security identifier for BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock used to aggregate holder disclosures.

How many institutions held BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock in Q4 2019?

454 institutional investors reported BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock for Q4 2019. Use the holders table for investor-level position and value details.

BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN)

CUSIP: 09061G101

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class: Equity / Common Stock
Shares outstanding: 192,632,743
Total 13F shares: 173,399,113
Share change: -851,692
Total reported value: $14,656,072,034
Put/Call ratio: 94%
Price per share: $84.55
Number of holders: 454
Value change: +$53,952,753
Number of buys: 235
Number of sells: 173

Quarterly Holders Quick Answers

What is CUSIP 09061G101?
CUSIP 09061G101 identifies BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2020
Previous quarter: Q3 2019

Recent filing periods for CUSIP 09061G101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Capital Research Global Investors	13F	Company	11%	21,707,664	$1,463,097,000	—	30 Sep 2019	13F
VANGUARD GROUP INC	13F	Company	8.6%	16,482,444	$1,110,917,000	—	30 Sep 2019	13F
PRIMECAP MANAGEMENT CO/CA/	13F	Company	7.9%	15,162,074	$1,021,924,000	—	30 Sep 2019	13F
BlackRock Finance, Inc.	13F	Company	6.7%	12,900,713	$869,507,000	—	30 Sep 2019	13F
JENNISON ASSOCIATES LLC	13F	Company	4.3%	8,331,400	$561,536,000	—	30 Sep 2019	13F
BAKER BROS. ADVISORS LP	13F	Company	3.9%	7,589,294	$511,518,000	—	30 Sep 2019	13F
Clearbridge Investments, LLC	13F	Company	3.1%	6,042,714	$407,279,000	—	30 Sep 2019	13F
SANDS CAPITAL MANAGEMENT, LLC	13F	Company	2.9%	5,565,620	$375,123,000	—	30 Sep 2019	13F
STATE STREET CORP	13F	Company	2.5%	4,875,782	$328,628,000	—	30 Sep 2019	13F
VIKING GLOBAL INVESTORS LP	13F	Company	1.6%	3,058,104	$206,116,000	—	30 Sep 2019	13F
AMERIPRISE FINANCIAL INC	13F	Company	1.5%	2,891,622	$194,898,000	—	30 Sep 2019	13F
Capital International Investors	13F	Company	1.3%	2,565,783	$172,934,000	—	30 Sep 2019	13F
Capital World Investors	13F	Company	1.3%	2,491,786	$167,946,000	—	30 Sep 2019	13F
Avoro Capital Advisors LLC	13F	Company	1.3%	2,437,100	$164,261,000	—	30 Sep 2019	13F
Temasek Holdings (Private) Ltd	13F	Company	1.2%	2,372,712	$159,921,000	—	30 Sep 2019	13F
Invesco Ltd.	13F	Company	1.2%	2,248,162	$151,526,000	—	30 Sep 2019	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1.2%	2,244,321	$151,267,000	—	30 Sep 2019	13F
Palo Alto Investors LP	13F	Company	1.1%	2,209,504	$148,921,000	—	30 Sep 2019	13F
PFM Health Sciences, LP	13F	Company	1.1%	2,149,051	$144,846,000	—	30 Sep 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.95%	1,828,200	$123,131,000	—	30 Sep 2019	13F
CITADEL ADVISORS LLC	13F	Company	0.91%	1,757,230	$118,438,000	—	30 Sep 2019	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.83%	1,592,010	$107,301,000	—	30 Sep 2019	13F
NORGES BANK	13F	Company	0.78%	1,507,703	$101,621,000	—	30 Sep 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.76%	1,469,604	$99,051,000	—	30 Sep 2019	13F
Nuveen Asset Management, LLC	13F	Company	0.66%	1,279,476	$86,237,000	—	30 Sep 2019	13F
FRANKLIN RESOURCES INC	13F	Company	0.64%	1,232,867	$83,095,000	—	30 Sep 2019	13F
DEUTSCHE BANK AG\	13F	Company	0.63%	1,217,286	$82,035,000	—	30 Sep 2019	13F
NORTHERN TRUST CORP	13F	Company	0.62%	1,192,238	$80,358,000	—	30 Sep 2019	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.6%	1,152,646	$77,688,339	—	30 Sep 2019	13F
Legal & General Group Plc	13F	Company	0.5%	956,097	$64,434,000	—	30 Sep 2019	13F
FIRST TRUST ADVISORS LP	13F	Company	0.45%	857,225	$57,777,000	—	30 Sep 2019	13F
LOOMIS SAYLES & CO L P	13F	Company	0.43%	829,144	$55,885,000	—	30 Sep 2019	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.41%	796,150	$53,661,000	—	30 Sep 2019	13F
TCW GROUP INC	13F	Company	0.4%	772,908	$52,093,000	—	30 Sep 2019	13F
Bank of New York Mellon Corp	13F	Company	0.39%	756,640	$50,996,000	—	30 Sep 2019	13F
FRONTIER CAPITAL MANAGEMENT CO LLC	13F	Company	0.39%	752,902	$50,746,000	—	30 Sep 2019	13F
York Capital Management Global Advisors, LLC	13F	Company	0.39%	748,371	$50,440,000	—	30 Sep 2019	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.38%	738,900	$49,802,000	—	30 Sep 2019	13F
USS Investment Management Ltd	13F	Company	0.38%	735,000	$49,546,000	—	30 Sep 2019	13F
Manning & Napier Group, LLC	13F	Company	0.38%	730,093	$49,206,000	—	30 Sep 2019	13F
Sumitomo Mitsui Trust Group, Inc.	13F	Company	0.35%	672,523	$45,328,000	—	30 Sep 2019	13F
FMR LLC	13F	Company	0.31%	592,882	$39,960,000	—	30 Sep 2019	13F
Swiss National Bank	13F	Company	0.31%	591,332	$39,856,000	—	30 Sep 2019	13F
ZEVENBERGEN CAPITAL INVESTMENTS LLC	13F	Company	0.31%	590,340	$39,789,000	—	30 Sep 2019	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.31%	588,294	$39,651,000	—	30 Sep 2019	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.3%	586,719	$39,545,000	—	30 Sep 2019	13F
NATIXIS	13F	Company	0.29%	568,210	$38,297,000	—	30 Sep 2019	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.29%	556,071	$37,479,000	—	30 Sep 2019	13F
JPMORGAN CHASE & CO	13F	Company	0.28%	540,913	$36,457,000	—	30 Sep 2019	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.28%	533,604	$35,965,000	—	30 Sep 2019	13F

Institutional Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) as of Q4 2019

As of 31 Dec 2019, BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) was held by 454 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 173,399,113 shares. The largest 10 holders included Capital Research Global Investors, VANGUARD GROUP INC, PRIMECAP MANAGEMENT CO/CA/, BlackRock Inc., BAKER BROS. ADVISORS LP, JENNISON ASSOCIATES LLC, Clearbridge Investments, LLC, STATE STREET CORP, Dodge & Cox, and AMERIPRISE FINANCIAL INC. This page lists 455 institutional shareholders reporting positions in this security for the Q4 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2019 vs Q3 2019 Across Filers

Q3 2019 holders

427

Q4 2019 holders

454

Holder diff

Investor	Q3 2019 Shares	Q4 2019 Shares	Share Diff	Share Chg %	Q3 2019 Value $	Q4 2019 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.